03:02 AM EDT, 10/29/2024 (MT Newswires) -- Greg Zante, Chief Financial Officer, on October 28, 2024, sold 131,687 shares in Viking Therapeutics ( VKTX ) for $10,089,164. Following the Form 4 filing with the SEC, Zante has control over a total of 149,366 shares of the company, with 149,366 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1607678/000095017024117885/xslF345X05/ownership.xml
Price: 74.83, Change: +0.31, Percent Change: +0.42